Orthocell Limited (OCC.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.5050-0.0350 (-6.48%)
At close: 4:10PM AEST
| Previous close | 0.5400 |
| Open | 0.5350 |
| Bid | 0.5050 x 3162600 |
| Ask | 0.5400 x 365000 |
| Day's range | 0.5050 - 0.5350 |
| 52-week range | 0.2950 - 0.6450 |
| Volume | 287,373 |
| Avg. volume | 443,551 |
| Market cap | 95.537M |
| Beta (5Y monthly) | 0.36 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0460 |
| Earnings date | 27 Aug 2018 - 31 Aug 2018 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Orthocell Receives US Market Clearance
Australian-based regenerative medicine company, Orthocell Ltd (ASX:OCC, "Orthocell" or the "Company"), has achieved US 510k clearance to market and supply its collagen medical device Striate+TM in the US dental bone and tissue regeneration market.
- Simply Wall St.
We Think Orthocell (ASX:OCC) Can Afford To Drive Business Growth
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
- Simply Wall St.
How Much Is Orthocell Limited (ASX:OCC) CEO Getting Paid?
The CEO of Orthocell Limited (ASX:OCC) is Paul Anderson, and this article examines the executive's compensation...
© 2021 Verizon Media. All rights reserved.
